Shah, Anand
Polascik, Thomas J.
George, Daniel J.
Anderson, John
Hyslop, Terry
Ellis, Alicia M.
Armstrong, Andrew J.
Ferrandino, Michael
Preminger, Glenn M.
Gupta, Rajan T.
Lee, W. Robert
Barrett, Nadine J.
Ragsdale, John
Mills, Coleman
Check, Devon K.
Aminsharifi, Alireza
Schulman, Ariel
Sze, Christina
Tsivian, Efrat
Tay, Kae Jack
Patierno, Steven
Oeffinger, Kevin C.
Shah, Kevin http://orcid.org/0000-0002-6938-698X
Funding for this research was provided by:
National Cancer Institute (P30CA014236)
Duke Institute for Healthcare Innovation
Article History
Received: 8 August 2019
Accepted: 7 August 2020
First Online: 1 September 2020
Compliance with Ethical Standards
: This study was reviewed and deemed exempt by the Duke Institutional Review Board.
: Thomas J. Polascik reports consultancies in the last 3 years and honoraria in the last 3 years from Healthtronics [training agreement]. Terry Hyslop reports consultancies in the last 3 years from AbbVie. Glenn M. Preminger reports consultancies in the last 3 years from Boston Scientific, Auris Robotics, and Kalera Medical and reports other relationships as an Associate Editor for Up to Date. Kevin Shah reports stock ownership/options other than mutual funds from Infinity Pharmaceuticals. Anand Shah reports stock ownership/options other than mutual funds from Pfizer Inc. All other authors report no conflict of interest.
Free to read: This content has been made available to all.